# Kangduo Robotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kangduo-robotics

- Industry: Hardware
- Headquarters: Suzhou, China
- Latest round: Series A (Dec 30, 2024)
- Investors on record: 1

## About

Founded in 2014 and based in China, Kangduo Robotics Co., Ltd., trading as Kangduo Robotics, specializes in laparoscopic surgical robot development and industrialization. The company introduced its first product, the SR1000, which received NMPA approval in June 2022 for urology applications and later for gynecology, general surgery, and thoracic surgery. Its SR1500 variant obtained additional approval in April 2024, and the four-arm SR2000 version was approved in July 2024. Kangduo Robotics has also been active in clinical trials and academic presentations, including collaborations with Peking University-affiliated hospitals and studies published in top surgical journals. In May 2025, Kangduo Robotics raised a venture funding from new investor Yuhuan State-owned Assets Investment and Management Group.

The company offers a family of laparoscopic surgical robotic systems SR1000, SR1500 (enhanced configuration), and SR2000 (four-arm with multi-screen console) designed for precise control, tremor reduction, and surgeon ergonomics. Systems operate with 3D endoscopic visualization and multi-modal navigation, and Kangduo supports clinical training, system integration, and device servicing.

The company generates revenue through equipment sales and related services, including installation, training, clinical deployments, and test-type devices. Initial revenue has progressed through institutional pilot placements and hospital procurement contracts.

## Funding rounds

- Series A, Dec 30, 2024 — Jiuyou Fund

## Investors

- Jiuyou Fund (https://capitalatlas.ai/funds/jiuyou-fund) — Series A